Suppr超能文献

基于人群的队列研究中 ALS 各临床阶段的认知障碍。

Cognitive impairment across ALS clinical stages in a population-based cohort.

机构信息

From the ALS Center (A. Chiò, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza of Torino (A. Chiò, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chiò), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carità, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.

出版信息

Neurology. 2019 Sep 3;93(10):e984-e994. doi: 10.1212/WNL.0000000000008063. Epub 2019 Aug 13.

Abstract

OBJECTIVE

To assess the association of the degree of severity of motor impairment to that of cognitive impairment in a large cohort of patients with amyotrophic lateral sclerosis (ALS).

METHODS

This is a population-based cross-sectional study on patients with ALS incident in Piemonte, Italy, between 2007 and 2015. Cognitive status was classified according to the revised ALS-FTD Consensus Criteria. The King system and the Milano Torino Staging system (MiToS) were used for defining the severity of motor impairment.

RESULTS

Of the 797 patients included in the study, 163 (20.5%) had ALS-frontotemporal dementia (FTD), 38 (4.8%) cognitive and behavioral impairment (ALScbi), 132 (16.6%) cognitive impairment (ALSci), 63 (7.9%) behavioral impairment (ALSbi), 16 (2.0%) nonexecutive impairment, and 385 (48.2%) were cognitively normal. According to King staging, the frequency of cases with ALS-FTD progressively increased from 16.5% in stage 1-44.4% in stage 4; conversely, the frequency of ALSci, ALSbi, and ALScbi increased from King stage 1 to King stage 3 and decreased thereafter. A similar pattern was observed with the MiToS staging. ALS-FTD was more frequent in patients with bulbar involvement at time of cognitive testing. Patients with expansion (n = 61) showed more severe cognitive impairment with increasing King and MiToS stages.

CONCLUSION

Our findings suggest that ALS motor and cognitive components may worsen in parallel, and that cognitive impairment becomes more pronounced when bulbar function is involved. Our data support the hypothesis that ALS pathology disseminates in a regional ordered sequence, through a cortico-efferent spreading model.

摘要

目的

在一个大型肌萎缩侧索硬化症(ALS)患者队列中,评估运动障碍严重程度与认知障碍严重程度之间的相关性。

方法

这是一项基于人群的横断性研究,研究对象为 2007 年至 2015 年间在意大利皮埃蒙特新诊断的 ALS 患者。认知状态根据修订后的 ALS-FTD 共识标准进行分类。King 系统和米兰-都灵分期系统(MiToS)用于定义运动障碍的严重程度。

结果

在纳入研究的 797 例患者中,163 例(20.5%)患有肌萎缩侧索硬化症-额颞叶痴呆(ALS-FTD),38 例(4.8%)患有认知和行为障碍(ALScbi),132 例(16.6%)患有认知障碍(ALSci),63 例(7.9%)患有行为障碍(ALSbi),16 例(2.0%)患有非执行功能障碍,385 例(48.2%)认知正常。根据 King 分期,ALS-FTD 的发生率从 1 期的 16.5%逐渐增加到 4 期的 44.4%;相反,ALSci、ALSbi 和 ALScbi 的发生率从 King 1 期增加到 King 3 期,然后降低。MiToS 分期也观察到类似的模式。在认知测试时,伴有球部受累的患者更常发生 ALS-FTD。携带扩展(n = 61)的患者,随着 King 和 MiToS 分期的增加,认知障碍更为严重。

结论

我们的研究结果表明,ALS 的运动和认知成分可能会同时恶化,当球部功能受累时,认知障碍会更加明显。我们的数据支持 ALS 病理学通过皮质传出扩散模型呈区域性有序传播的假说。

相似文献

1
Cognitive impairment across ALS clinical stages in a population-based cohort.
Neurology. 2019 Sep 3;93(10):e984-e994. doi: 10.1212/WNL.0000000000008063. Epub 2019 Aug 13.
2
ALS phenotype is influenced by age, sex, and genetics: A population-based study.
Neurology. 2020 Feb 25;94(8):e802-e810. doi: 10.1212/WNL.0000000000008869. Epub 2020 Jan 6.
3
Validation of the revised classification of cognitive and behavioural impairment in ALS.
J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):734-739. doi: 10.1136/jnnp-2018-319696. Epub 2019 Feb 7.
4
Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies.
Neurosci Lett. 2021 May 29;754:135898. doi: 10.1016/j.neulet.2021.135898. Epub 2021 Apr 15.
5
The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.
JAMA Neurol. 2016 Apr;73(4):425-30. doi: 10.1001/jamaneurol.2015.4773.
6
Prevalence and motor-functional correlates of frontotemporal-spectrum disorders in a large cohort of non-demented ALS patients.
J Neurol. 2024 Oct;271(10):6944-6955. doi: 10.1007/s00415-024-12658-w. Epub 2024 Sep 5.
8
Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.
PLoS One. 2014 Feb 3;9(2):e87163. doi: 10.1371/journal.pone.0087163. eCollection 2014.
9
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis.
J Neurol. 2024 Feb;271(2):955-961. doi: 10.1007/s00415-023-12056-8. Epub 2023 Oct 25.
10
Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the Pathogenic Variant.
Neurology. 2024 Feb 27;102(4):e208082. doi: 10.1212/WNL.0000000000208082. Epub 2024 Jan 23.

引用本文的文献

1
Thalamic nuclei volumes are related to disease stage in patients with amyotrophic lateral sclerosis.
Front Neurosci. 2025 Jul 11;19:1616239. doi: 10.3389/fnins.2025.1616239. eCollection 2025.
4
New developments in imaging in ALS.
J Neurol. 2025 May 12;272(6):392. doi: 10.1007/s00415-025-13143-8.

本文引用的文献

1
Validation of the revised classification of cognitive and behavioural impairment in ALS.
J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):734-739. doi: 10.1136/jnnp-2018-319696. Epub 2019 Feb 7.
2
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS.
Neurology. 2018 Oct 9;91(15):e1370-e1380. doi: 10.1212/WNL.0000000000006317. Epub 2018 Sep 12.
3
Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS).
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):387-395. doi: 10.1080/21678421.2018.1473443. Epub 2018 May 26.
4
Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis.
Neurol Clin Pract. 2017 Dec;7(6):488-498. doi: 10.1212/CPJ.0000000000000397.
5
Brain-Computer Interface for Clinical Purposes: Cognitive Assessment and Rehabilitation.
Biomed Res Int. 2017;2017:1695290. doi: 10.1155/2017/1695290. Epub 2017 Aug 23.
6
Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.
JAMA Neurol. 2017 Sep 1;74(9):1097-1104. doi: 10.1001/jamaneurol.2017.1387.
7
Amyotrophic lateral sclerosis.
Lancet. 2017 Nov 4;390(10107):2084-2098. doi: 10.1016/S0140-6736(17)31287-4. Epub 2017 May 25.
8
An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS.
J Neurol. 2017 Jun;264(6):1136-1145. doi: 10.1007/s00415-017-8506-z. Epub 2017 May 13.
9
Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.
J Alzheimers Dis. 2017;58(1):163-170. doi: 10.3233/JAD-161272.
10
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174. doi: 10.1080/21678421.2016.1267768. Epub 2017 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验